95 related articles for article (PubMed ID: 2514979)
1. Effects of an analogue of thyrotrophin-releasing hormone, RX77368, on infarct size and cerebral blood flow in focal cerebral ischaemia in the rat.
O'Shaughnessy CT; Rothwell NJ; Shrewsbury-Gee J
Can J Physiol Pharmacol; 1989 Oct; 67(10):1345-50. PubMed ID: 2514979
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term administration of JTP-2942, a novel thyrotropin-releasing hormone analogue, on neurological outcome, local cerebral blood flow and glucose utilization in a rat focal cerebral ischemia.
Katsumata T; Katayama Y; Ootori T; Muramatsu H; Nishiyama Y; Nakamura H; Seta T; Terashi A
Brain Res; 2001 May; 901(1-2):62-70. PubMed ID: 11368951
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the motor behaviours produced by the intrathecal administration of thyrotrophin-releasing hormone and thyrotrophin-releasing hormone analogues in the conscious rat.
Johnson JV; Fone KC; Havler ME; Tulloch IF; Bennett GW; Marsden CA
Neuroscience; 1989; 29(2):463-70. PubMed ID: 2498761
[TBL] [Abstract][Full Text] [Related]
4. Delayed administration of JTP-2942, a novel thyrotropin-releasing hormone analogue, improves cerebral blood flow and metabolism in rat postischaemic brain.
Katsumata T; Katayama Y; Yonemori H; Muramatsu H; Otori T; Nishiyama Y; Yamada H; Nakamura H; Terashi A
Clin Exp Pharmacol Physiol; 2001; 28(1-2):48-54. PubMed ID: 11153536
[TBL] [Abstract][Full Text] [Related]
5. Effect of a thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test.
Ballard TM; Hunter AJ; Bennett GW
Psychopharmacology (Berl); 1996 Oct; 127(3):265-75. PubMed ID: 8912405
[TBL] [Abstract][Full Text] [Related]
6. The effects of TRH analogues on cerebral ischaemia produced by middle cerebral artery occlusion in the rat.
Shrewsbury-Gee J; Lye RH; Latham A; Slater P
Exp Brain Res; 1988; 70(2):342-50. PubMed ID: 3133237
[TBL] [Abstract][Full Text] [Related]
7. Motoneurone excitability after administration of a thyrotrophin releasing hormone analogue.
Clarke KA; Stirk G
Br J Pharmacol; 1983 Nov; 80(3):561-5. PubMed ID: 6416344
[TBL] [Abstract][Full Text] [Related]
8. Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat.
Park CK; Nehls DG; Teasdale GM; McCulloch J
J Cereb Blood Flow Metab; 1989 Oct; 9(5):617-22. PubMed ID: 2674169
[TBL] [Abstract][Full Text] [Related]
9. Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease.
Guiloff RJ; Eckland DJ; Demaine C; Hoare RC; MacRae KD; Lightman SL
J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1359-70. PubMed ID: 3119776
[TBL] [Abstract][Full Text] [Related]
10. Behavioral profile of the TRH analogue RX77368 in developing rats.
Jackson HC
Peptides; 1990; 11(5):897-901. PubMed ID: 2126622
[TBL] [Abstract][Full Text] [Related]
11. Development of a radioimmunoassay for RX77368 (pGlu-His-3,3-dimethyl proline amide)--a stable analogue of thyrotrophin releasing hormone (TRH).
Lynn AG; Bennett GW
J Pharm Biomed Anal; 1991; 9(1):9-18. PubMed ID: 1904280
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin-releasing hormone (TRH) acts centrally to stimulate gastric contractility in rats.
Garrick T; Buack S; Veiseh A; Tache Y
Life Sci; 1987 Feb; 40(7):649-57. PubMed ID: 3100898
[TBL] [Abstract][Full Text] [Related]
13. The effects of gamma 2-melanocyte-stimulating hormone and nimodipine on cortical blood flow and infarction volume in two rat models of middle cerebral artery occlusion.
Herz RC; De Wildt DJ; Versteeg DH
Eur J Pharmacol; 1996 Jun; 306(1-3):113-21. PubMed ID: 8813623
[TBL] [Abstract][Full Text] [Related]
14. Effects of a thyrotropin releasing hormone analogue on locomotor and other motor activity in the rat.
Clarke KA; Parker AJ
Neuropeptides; 1985 Apr; 6(2):101-12. PubMed ID: 3923383
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-releasing hormone analogue and serotonin interact within the dorsal vagal complex to augment gastric acid secretion.
McTigue DM; Rogers RC; Stephens RL
Neurosci Lett; 1992 Sep; 144(1-2):61-4. PubMed ID: 1436715
[TBL] [Abstract][Full Text] [Related]
16. Focal cerebral ischaemia in the rat: 2. Regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion.
Tamura A; Graham DI; McCulloch J; Teasdale GM
J Cereb Blood Flow Metab; 1981; 1(1):61-9. PubMed ID: 7328139
[TBL] [Abstract][Full Text] [Related]
17. Further studies on the effects of a thyrotropin releasing hormone analogue on locomotor activity in the rat.
Clarke KA; Parker AJ
Neuropeptides; 1986; 8(2):99-109. PubMed ID: 3093913
[TBL] [Abstract][Full Text] [Related]
18. Effect of opiate antagonists on middle cerebral artery occlusion infarct in the rat.
Obana WG; Pitts LH; Nishimura MC
J Neurosurg; 1988 Jul; 69(1):98-103. PubMed ID: 3132541
[TBL] [Abstract][Full Text] [Related]
19. Focal cerebral ischaemia induces corticotropin releasing factor (CRF) vascular immunoreactivity in rat occluded hemisphere.
De Michele M; Sette G; Chalmers DT; Dewar D; Toni D; Sancesario G; McCulloch J
Regul Pept; 2007 Oct; 143(1-3):69-75. PubMed ID: 17477982
[TBL] [Abstract][Full Text] [Related]
20. Effect of low intravenous doses of TRH, acid-TRH and cyclo(His-Pro) on cerebral and peripheral blood flows.
Koskinen LO
Br J Pharmacol; 1986 Mar; 87(3):509-19. PubMed ID: 3099875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
